Silintan is a dietary supplement marketed as a treatment for joint and body aches. According to a recent analysis by the FDA, however, all lots contained undeclared meloxicam, creating an increased risk of adverse events.

Financial literacy is no longer optional for physicians. “If you're not financially viable, you can't function,” explained Nirat Beohar, MD. “The business education is probably just as important as learning a new procedure.”

The new policy applies to all health plans across Pennsylvania, New York, West Virginia and Delaware, “removing financial barriers for essential breast cancer diagnostics.”

Under terms of the deal, Carestream is unloading its international operations to Midea Group, a Chinese electrical appliance manufacturer. 

AI is an icy landslide sweeping through healthcare. Even surgeons must choose between two stark options: Ride the crest of the powder cloud now or dig yourselves out of a deep runout zone later. 

The U.S. Department of Justice alleges that 52-year-old Ritesh Kalra, MD, wrote 50 prescriptions a day for addictive painkillers and billed New Jersey Medicaid for patient visits that never occurred. The alleged incidents occurred between 2019 and 2025.

Numerous “alternative funding programs” are named as defendants in what is a larger challenge of the right of these third-party organizations to import drugs from overseas, bypassing FDA regulations. 

Philadelphia-based Jefferson Health has accused the three biggest PBMs—Caremark, Express Scripts and Optum Rx—of a de facto collusion scheme involving the primary makers of insulin, Eli Lilly, Novo Nordisk and Sanofi. The lawsuit alleges rebates offered by the manufacturers unfairly burden self-insured and public health plans, like the one the health system uses for its employees.